Gerresheimer AG (ETR:GXI) has been given a consensus rating of “Hold” by the nine brokerages that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is €79.80 ($93.88).

Several equities research analysts have recently commented on GXI shares. Independent Research GmbH set a €78.00 ($91.76) target price on shares of Gerresheimer AG and gave the stock a “neutral” rating in a research report on Wednesday, July 19th. Berenberg Bank set a €85.00 ($100.00) target price on shares of Gerresheimer AG and gave the stock a “buy” rating in a research report on Wednesday, May 24th. DZ Bank AG reissued a “buy” rating on shares of Gerresheimer AG in a research report on Monday, July 17th. Deutsche Bank AG set a €82.00 ($96.47) target price on shares of Gerresheimer AG and gave the stock a “buy” rating in a research report on Friday, July 7th. Finally, Kepler Capital Markets set a €70.00 ($82.35) target price on shares of Gerresheimer AG and gave the stock a “sell” rating in a research report on Thursday, July 13th.

Shares of Gerresheimer AG (ETR:GXI) traded down 0.162% during trading on Tuesday, hitting €69.188. The stock had a trading volume of 100 shares. The firm has a 50-day moving average of €71.04 and a 200 day moving average of €73.13. Gerresheimer AG has a 1-year low of €64.00 and a 1-year high of €79.47. The company has a market capitalization of €2.17 billion and a P/E ratio of 19.166.

ILLEGAL ACTIVITY NOTICE: “Gerresheimer AG (ETR:GXI) Receives €79.80 Consensus Target Price from Brokerages” was posted by Daily Political and is owned by of Daily Political. If you are reading this news story on another site, it was stolen and reposted in violation of US and international copyright and trademark laws. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/08/04/gerresheimer-ag-etrgxi-receives-79-80-consensus-target-price-from-brokerages.html.

Gerresheimer AG Company Profile

Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings.

Analyst Recommendations for Gerresheimer AG (ETR:GXI)

Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.